Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Libra

Showing results (31-40 of 293) with videos related to

Pageof 30
Sort By:
Tumori|May 7, 2002
Carboplatin in elderly patientsRoberto Sorio, Renata Talamini, Giuseppe Toffoli, et al.
International Journal of Oncology|June 26, 2020
Cutaneous melanoma and the immunotherapy revolution (Review)Giulia C Leonardi, Saverio Candido, Luca Falzone, et al.
Gut Microbes|September 4, 2024
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing <i>Escherichia coli</i> Nissle 1917 strainLuca Falzone, Alessandro Lavoro, Saverio Candido, et al.
Cancers|September 11, 2020
Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical ActivityLuca Falzone, Maria Grimaldi, Egidio Celentano, et al.
Recent Patents on Anti-Infective Drug Discovery|May 26, 2010
New perspectives in HCV therapy: entry inhibitorsMarco Donia, Bruno Cacopardo, Massimo Libra, et al.
Molecular Medicine Reports|March 4, 2016
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritisSalvatore Santo Signorelli, Saverio Candido, Rossella Salemi, et al.
Expert Opinion on Drug Discovery|April 6, 2016
Computational modeling in melanoma for novel drug discoveryMarzio Pennisi, Giulia Russo, Valentina Di Salvatore, et al.
Cancers|August 14, 2020
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?Silvia Vivarelli, Luca Falzone, Caterina Maria Grillo, et al.
Frontiers in Pharmacology|July 3, 2023
<i>In silico</i> analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivityAlessandro Lavoro, Luca Falzone, Barbara Tomasello, et al.
Molecular Medicine Reports|March 25, 2017
Epigenetic alterations and occupational exposure to benzene, fibers, and heavy metals associated with tumor development (Review)Rossella Salemi, Andrea Marconi, Valentina Di Salvatore, et al.
Pageof 30

Showing results (31-40 of 293) with videos related to

Sort By:
Pageof 30
Tumori|May 7, 2002
Carboplatin in elderly patientsRoberto Sorio, Renata Talamini, Giuseppe Toffoli, et al.
International Journal of Oncology|June 26, 2020
Cutaneous melanoma and the immunotherapy revolution (Review)Giulia C Leonardi, Saverio Candido, Luca Falzone, et al.
Gut Microbes|September 4, 2024
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing <i>Escherichia coli</i> Nissle 1917 strainLuca Falzone, Alessandro Lavoro, Saverio Candido, et al.
Cancers|September 11, 2020
Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical ActivityLuca Falzone, Maria Grimaldi, Egidio Celentano, et al.
Recent Patents on Anti-Infective Drug Discovery|May 26, 2010
New perspectives in HCV therapy: entry inhibitorsMarco Donia, Bruno Cacopardo, Massimo Libra, et al.
Molecular Medicine Reports|March 4, 2016
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritisSalvatore Santo Signorelli, Saverio Candido, Rossella Salemi, et al.
Expert Opinion on Drug Discovery|April 6, 2016
Computational modeling in melanoma for novel drug discoveryMarzio Pennisi, Giulia Russo, Valentina Di Salvatore, et al.
Cancers|August 14, 2020
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?Silvia Vivarelli, Luca Falzone, Caterina Maria Grillo, et al.
Frontiers in Pharmacology|July 3, 2023
<i>In silico</i> analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivityAlessandro Lavoro, Luca Falzone, Barbara Tomasello, et al.
Molecular Medicine Reports|March 25, 2017
Epigenetic alterations and occupational exposure to benzene, fibers, and heavy metals associated with tumor development (Review)Rossella Salemi, Andrea Marconi, Valentina Di Salvatore, et al.
Pageof 30